Shares of United-Guardian, Inc. (NASDAQ:UG – Get Free Report) passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $7.26 and traded as low as $7.08. United-Guardian shares last traded at $7.14, with a volume of 5,812 shares traded.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded United-Guardian from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, July 21st. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.
Read Our Latest Research Report on United-Guardian
United-Guardian Stock Up 1.4%
United-Guardian (NASDAQ:UG – Get Free Report) last released its earnings results on Friday, August 7th. The company reported $0.16 earnings per share for the quarter. United-Guardian had a return on equity of 22.24% and a net margin of 22.01%.The company had revenue of $3.11 million for the quarter.
United-Guardian Announces Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, August 4th. Stockholders of record on Tuesday, July 28th were given a dividend of $0.30 per share. This represents a dividend yield of 819.0%. The ex-dividend date of this dividend was Tuesday, July 28th. United-Guardian’s payout ratio is presently 111.11%.
Institutional Investors Weigh In On United-Guardian
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. United Capital Financial Advisors LLC purchased a new position in shares of United-Guardian during the 2nd quarter valued at $143,000. BlackRock Inc. purchased a new stake in United-Guardian in the 2nd quarter worth $105,000. Finally, Gamco Investors INC. ET AL raised its holdings in United-Guardian by 1.2% during the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock valued at $1,101,000 after acquiring an additional 1,888 shares during the period. 23.16% of the stock is owned by hedge funds and other institutional investors.
United-Guardian Company Profile
United-Guardian, Inc develops, manufactures, and markets specialty products for the personal care, pharmaceutical, medical, and industrial markets. The company’s products are used by manufacturers in formulations including cosmetics, skin-care products, pharmaceuticals, and medical treatments.
United-Guardian’s product portfolio includes Lubrajel, a water-soluble lubricating and moisturizing agent used in personal-care and pharmaceutical applications, as well as Renacidin, a medical solution used for the dissolution and prevention of certain urinary tract calculi and encrustations.
Read More
- Five stocks we like better than United-Guardian
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for United-Guardian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian and related companies with MarketBeat.com's FREE daily email newsletter.
